![Michael Schmelmer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Schmelmer
Algemeen Directeur bij Boehringer Ingelheim Verwaltungs GmbH
Profiel
Michael Schmelmer is currently the Co-Managing Director at Anasco GmbH, BIOTHERAX biochemisch-pharmazeutische GmbH, Boehringer Ingelheim Verwaltungs GmbH, Boehringer Ingelheim Auslandsbeteiligungs GmbH, and the Member-Management Board at C.H.
Boehringer Sohn AG & Co. KG.
Actieve functies van Michael Schmelmer
Bedrijven | Functie | Begin |
---|---|---|
Boehringer Ingelheim Verwaltungs GmbH
![]() Boehringer Ingelheim Verwaltungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Verwaltungs GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs are Andreas Neumann, Michael Schmelmer. The company was founded in 2007. | Algemeen Directeur | - |
Anasco GmbH /DE/
![]() Anasco GmbH /DE/ Financial ConglomeratesFinance Anasco GmbH is a company based in Ingelheim am Rhein, Germany. Part of C.H. Boehringer Sohn AG & Co. KG, Anasco GmbH provides investment services. The German company was founded in 1992, and the CEOs are Frank Hübler and Michael Schmelmer. | Algemeen Directeur | 26-01-2018 |
BIOTHERAX biochemisch-pharmazeutische GmbH
![]() BIOTHERAX biochemisch-pharmazeutische GmbH Pharmaceuticals: MajorHealth Technology BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck. | Algemeen Directeur | - |
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - |
Boehringer Ingelheim Auslandsbeteiligungs GmbH
![]() Boehringer Ingelheim Auslandsbeteiligungs GmbH MiscellaneousMiscellaneous Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Anasco GmbH /DE/
![]() Anasco GmbH /DE/ Financial ConglomeratesFinance Anasco GmbH is a company based in Ingelheim am Rhein, Germany. Part of C.H. Boehringer Sohn AG & Co. KG, Anasco GmbH provides investment services. The German company was founded in 1992, and the CEOs are Frank Hübler and Michael Schmelmer. | Finance |
BIOTHERAX biochemisch-pharmazeutische GmbH
![]() BIOTHERAX biochemisch-pharmazeutische GmbH Pharmaceuticals: MajorHealth Technology BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck. | Health Technology |
Boehringer Ingelheim Verwaltungs GmbH
![]() Boehringer Ingelheim Verwaltungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Verwaltungs GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs are Andreas Neumann, Michael Schmelmer. The company was founded in 2007. | Finance |
Boehringer Ingelheim Auslandsbeteiligungs GmbH
![]() Boehringer Ingelheim Auslandsbeteiligungs GmbH MiscellaneousMiscellaneous Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim. | Miscellaneous |